Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma

Turkish Journal of Medical Sciences
Medicine
2019English

Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients With Non-Hodgkin's Lymphoma (NHL)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Autologous Stem Cell Transplantation Outcomes in Elderly Patients With B Cell Non-Hodgkin Lymphoma

British Journal of Haematology
Hematology
2015English

PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Significance of Salvage Autologous Stem Cell Transplantation (ASCT) for Patients With Multiple Myeloma Relapsing After Up-Front ASCT

Journal of Hematopoietic Cell Transplantation
2017English

Outcomes of Patients With Relapsed/Refractory Hodgkin Lymphoma Progressing After Autologous Stem Cell Transplant in the Current Era of Novel Therapeutics: A Retrospective Analysis

American Journal of Hematology
Hematology
2017English

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy